It represents an interesting option for patients refractory to or dependent on corticoste-roid therapy.
12 According to the patient's condition and preferences, it represents an additional option to third-generation emollients and other innovative sources, which represent the baseline treatment.
Although liraglutide is currently only licensed for the treatment of people with type 2 diabetes, it represents an attractive option for the treatment of obese women with PCOS.
Although the mechanism through which astemizole modulates autophagy, and the ability of astemizole to restore autophagy in CF remain entirely uncharacterized, it represents an attractive option for autophagy induction therapy in CF-associated lung infections due to its previously reported antifungal and antimalaria effects.
It represents a promising option to be considered in standardization efforts in the field of photocatalysis.
It represents a practical option for a no-bleed treatment, ensuring both high endometrial protection and the inherent safety linked to administrating physiologic hormones nonorally.
This direct method of following quantitatively the formation of an oxidation product was found to be accurate, highly sensitive and reproducible, therefore, it represents a promising option to be considered in standardization efforts in the field of photocatalysis.
It represents a valid option in geriatrics patients with venous insufficiency.
Bevacizumab (Avastin®), a recombinant humanized monoclonal antibody directed against VEGF, is currently approved for the treatment of many solid tumors and it represents a valid option for treatment of HER2-negative metastatic breast cancer (mBC) patients [ 5, 6].
In contrast to the overall tendency against routine metal removal, 68.9% of all respondents agreed that it represents a therapeutic option in case of otherwise unexplained pain and functional deficits (disagreement: 19.0%).
Therefore, based on the fact that glucosamine has low and rare adverse effects, it represents a viable option for the management of OA (as a symptomatic slow acting drug) but its administration should be discontinued if no significant effect is reported by the patient.
